SAHAJANAND MEDICAL TECH L (SMT) financials

SAHAJANAND MEDICAL TECH L (SMT) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Sahajanand Medical Technologies Ltd (SMT) develops and manufactures Class III /Class C-D cardiovascular devices used in vascular and structural-heart interventions. Its main products include coronary stents and balloons, TAVI heart valves and congenital-heart occluders. It sold products across 77 countries in FY26.[1]

Market Cap: ₹3,844Cr.
Current Price: ₹378
Stock P/E: 90.8
ROE: 6.52%
ROCE: 7.34%
Book Value: ₹
Dividend Yield: 0.00%
52W High / Low: ₹410/347

Annual Mar 2026: sales ₹551 Cr, net profit ₹44 Cr.

SMT profit and loss (₹ Cr.)
Category	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales	403	439	436	474	530	551
Expenses	344	400	379	453	498	473
Operating Profit	58	40	57	21	32	78
OPM %	14%	9%	13%	4.5%	6%	14%
Other Income	-24	-8	13	4	-9	6
Interest	7	5	18	8	10	17
Depreciation	13	13	18	21	16	21
Profit before tax	15	13	34	-4	-3	46
Tax %	168%	107%	39%	792%	140%	6%
Net Profit	-10	-1	21	-34	-8	44
EPS in Rs	-1.16	-0.09	2.04	-3.40	-0.78	4.29
Dividend Payout %	0%	0%	0%	0%	0%	0%

SMT balance sheet (₹ Cr.)
Category	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	9	9	10	10	10	10
Reserves	421	525	678	621	612	668
Borrowings	27	50	41	90	175	211
Other Liabilities	143	121	144	178	212	201
Total Liabilities	599	704	872	899	1,008	1,090
Fixed Assets	40	60	63	100	94	92
CWIP	6	0	1	2	4	3
Investments	72	75	417	459	498	502
Other Assets	481	570	391	339	413	494
Total Assets	599	704	872	899	1,008	1,090

SMT cash flows (₹ Cr.)
Category	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	105	34	75	26	12	8
Cash from Investing Activity	-56	-91	-198	-58	-51	-52
Cash from Financing Activity	-55	83	95	31	63	14
Net Cash Flow	-5	26	-29	-1	24	-30
Free Cash Flow	98	18	57	38	-3	-0
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	197%	129%	156%	157%	83%	19%

SMT key ratios
Category	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	176	154	143	102	94	77
Inventory Days	310	245	226	244	234	274
Days Payable	342	205	130	92	119	131
Cash Conversion Cycle	144	194	239	255	209	219
Working Capital Days	144	124	114	29	-18	5
ROCE %	—	6%	8%	1%	3%	7%

SMTUpdated 23 Oct 2026, 18:01

Sahajanand Medical Tech L

SMTUpdated 23 Oct 2026, 18:01

Market Cap

₹3,844Cr.

Current Price

₹378

High / Low

₹410/347

Stock P/E

90.8

Book Value₹

Dividend Yield0.00%

ROCE7.34%

ROE6.52%

Face Value₹1.00

About

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2021	403	7	344	-24	13	15	168	-10	-1.16
Mar 2022	439	5	400	-8	13	13	107	-1	-0.09
Mar 2023	436	18	379	13	18	34	39	21	2.04
Mar 2024	474	8	453	4	21	-4	792	-34	-3.4
Mar 2025	530	10	498	-9	16	-3	140	-8	-0.78
Mar 2026	551	17	473	6	21	46	6	44	4.29

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2021	9	421	27	143	599	40	6	72	481	599
Mar 2022	9	525	50	121	704	60	0	75	570	704
Mar 2023	10	678	41	144	872	63	1	417	391	872
Mar 2024	10	621	90	178	899	100	2	459	339	899
Mar 2025	10	612	175	212	1008	94	4	498	413	1008
Mar 2026	10	668	211	201	1090	92	3	502	494	1090

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2021	105	-56	-55	-5
Mar 2022	34	-91	83	26
Mar 2023	75	-198	95	-29
Mar 2024	26	-58	31	-1
Mar 2025	12	-51	63	24
Mar 2026	8	-52	14	-30

Key ratios

Historical financial ratios

Category	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	176	154	143	102	94	77
Inventory Days	310	245	226	244	234	274
Days Payable	342	205	130	92	119	131
Cash Conversion Cycle	144	194	239	255	209	219
Working Capital Days	144	124	114	29	-18	5
ROCE %	—	6%	8%	1%	3%	7%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of SAHAJANAND MEDICAL TECH L (SMT)?

The reported market capitalisation for SAHAJANAND MEDICAL TECH L (SMT) is ₹3,844Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of SMT?

The current price shown for SAHAJANAND MEDICAL TECH L (SMT) on Fincrux is ₹378 with a 52-week high/low of ₹410/347.

What is the P/E ratio of SAHAJANAND MEDICAL TECH L (SMT)?

The stock P/E for SAHAJANAND MEDICAL TECH L (SMT) is 90.8 on Fincrux, with ROE at 6.52% and ROCE at 7.34%.

What are SMT annual sales and net profit?

For Mar 2026, SAHAJANAND MEDICAL TECH L (SMT) shows sales of ₹551 Cr and net profit of ₹44 Cr on the Fincrux profit & loss statement.

Where can I find SAHAJANAND MEDICAL TECH L (SMT) financials?

SAHAJANAND MEDICAL TECH L (SMT) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show SMT balance sheet and cash flow?

Yes. The SAHAJANAND MEDICAL TECH L (SMT) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 23 October 2026 at 18:01